Joel Greenblatt's CVS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 236,002 shares of CVS Health Corporation (CVS) worth $17.79 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2016, adding 615,182 shares. Largest reduction occurred in Q1 2020, reducing 462,604 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +28,084 | Add 0.00% | 28,083 | $57.19 |
| Q3 2013 | +16,523 | Add 58.84% | 44,606 | $56.74 |
| Q4 2013 | -40,318 | Reduce 90.39% | 4,288 | $71.60 |
| Q1 2014 | +3,334 | Add 77.75% | 7,622 | $74.91 |
| Q2 2014 | +58,174 | Add 763.24% | 65,796 | $75.37 |
| Q3 2014 | -56,448 | Reduce 85.79% | 9,348 | $79.59 |
| Q4 2014 | -4,194 | Reduce 44.87% | 5,154 | $96.24 |
| Q1 2015 | +267,133 | Add 5183.02% | 272,287 | $103.21 |
| Q2 2015 | -181,070 | Reduce 66.50% | 91,217 | $104.88 |
| Q3 2015 | -70,420 | Reduce 77.20% | 20,797 | $96.46 |
| Q4 2015 | -20,797 | Sold Out | 20,797 | $0.00 |
| Q1 2016 | +220,252 | New Buy | 220,252 | $103.73 |
| Q2 2016 | +431,750 | Add 196.03% | 652,002 | $95.74 |
| Q3 2016 | -211,343 | Reduce 32.41% | 440,659 | $88.99 |
| Q4 2016 | +615,182 | Add 139.61% | 1.06 M | $78.91 |
| Q1 2017 | +26,547 | Add 2.51% | 1.08 M | $78.50 |
| Q2 2017 | -321,294 | Reduce 29.68% | 761,094 | $80.46 |
| Q3 2017 | -33,840 | Reduce 4.45% | 727,254 | $81.32 |
| Q4 2017 | +224,542 | Add 30.88% | 951,796 | $72.50 |
| Q1 2018 | -439,502 | Reduce 46.18% | 512,294 | $62.21 |
| Q2 2018 | -260,349 | Reduce 50.82% | 251,945 | $64.35 |
| Q3 2018 | +280,980 | Add 111.52% | 532,925 | $78.72 |
| Q4 2018 | -245,253 | Reduce 46.02% | 287,672 | $65.52 |
| Q1 2019 | +395,737 | Add 137.57% | 683,409 | $53.93 |
| Q2 2019 | +347,789 | Add 50.89% | 1.03 M | $54.49 |
| Q3 2019 | -342,396 | Reduce 33.20% | 688,802 | $63.07 |
| Q4 2019 | +85,363 | Add 12.39% | 774,165 | $74.29 |
| Q1 2020 | -462,604 | Reduce 59.76% | 311,561 | $59.33 |
| Q2 2020 | -177,782 | Reduce 57.06% | 133,779 | $64.97 |
| Q3 2020 | +35,972 | Add 26.89% | 169,751 | $58.40 |
| Q4 2020 | -54,880 | Reduce 32.33% | 114,871 | $68.30 |
| Q1 2021 | -40,221 | Reduce 35.01% | 74,650 | $75.23 |
| Q2 2021 | -6,525 | Reduce 8.74% | 68,125 | $83.43 |
| Q3 2021 | +636 | Add 0.93% | 68,761 | $84.86 |
| Q4 2021 | +6,769 | Add 9.84% | 75,530 | $103.16 |
| Q1 2022 | -6,968 | Reduce 9.23% | 68,562 | $101.21 |
| Q2 2022 | +20,475 | Add 29.86% | 89,037 | $92.66 |
| Q3 2022 | -10,972 | Reduce 12.32% | 78,065 | $95.37 |
| Q4 2022 | +22,539 | Add 28.87% | 100,604 | $93.19 |
| Q1 2023 | +75,695 | Add 75.24% | 176,299 | $74.31 |
| Q2 2023 | -2,673 | Reduce 1.52% | 173,626 | $69.13 |
| Q3 2023 | -38,951 | Reduce 22.43% | 134,675 | $69.82 |
| Q4 2023 | -10,117 | Reduce 7.51% | 124,558 | $78.96 |
| Q1 2024 | -20,442 | Reduce 16.41% | 104,116 | $79.76 |
| Q2 2024 | +41,805 | Add 40.15% | 145,921 | $59.06 |
| Q3 2024 | -40,822 | Reduce 27.98% | 105,099 | $62.88 |
| Q4 2024 | +125,434 | Add 119.35% | 230,533 | $44.89 |
| Q1 2025 | -82,971 | Reduce 35.99% | 147,562 | $67.75 |
| Q2 2025 | +28,825 | Add 19.53% | 176,387 | $68.98 |
| Q3 2025 | +59,615 | Add 33.80% | 236,002 | $75.39 |
Joel Greenblatt's CVS Health Corporation Investment FAQs
Joel Greenblatt first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 28,083 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held CVS Health Corporation (CVS) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to CVS Health Corporation (CVS) was in Q4 2016, adding 1,055,841 shares worth $83.32 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 236,002 shares of CVS Health Corporation (CVS), valued at approximately $17.79 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 0.08% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in CVS Health Corporation (CVS) was 1,082,388 shares, as reported at the end of Q1 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.